GGrantIndex
← Leaderboards

William M Wuest

Harvard Medical School

$6,242,876
Attributed
$6,242,876
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $787.6K · FY201025
$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,242,876 · 3

By mechanism

R35$4,327,563 · 1
R01$1,838,119 · 1
F32$77,194 · 1

Top collaborators

No co-investigators on record.

Most similar at Harvard Medical School

Same institution · by research overlap

Others in their field

Top investigators on “Property

Research focus

PropertyNatural ProductsAnalogScaffoldGeneticProteomicsMolecular GeneticsEnvironmentMicrobial BiofilmsOrganic SynthesisMicrobiologyComplexAffectInterestBiologicalBiochemicalChemical SynthesisDesignSynthesis ChemistryCombatBacteriaEvaluationTherapeutic AgentsTranscriptomics

Grant awards (24)

Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors$421,686
R35 · FY2025 · GM · contact PI
Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors$421,686
R35 · FY2024 · GM · contact PI
Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors$72,913
R35 · FY2024 · GM · contact PI
Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors$30,380
R35 · FY2024 · GM · contact PI
Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors$421,686
R35 · FY2023 · GM · contact PI
Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors$14,637
R35 · FY2023 · GM · contact PI
Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors$10,891
R35 · FY2023 · GM · contact PI
Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors$421,686
R35 · FY2022 · GM · contact PI
Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors$58,544
R35 · FY2022 · GM · contact PI
Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors$491,373
R35 · FY2021 · GM · contact PI
Diversity Supplement: Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors$43,908
R35 · FY2021 · GM · contact PI
Administartive Supplement-UGSRE: Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors$8,170
R35 · FY2021 · GM · contact PI
Natural Product-Inspired Approaches Toward the Development of Antivirulence and Species-Specific Inhibitors$380,777
R35 · FY2020 · GM · contact PI
Tool Compounds to Probe Multispecies Biofilms in the Human Oral Microbiome$362,362
R01 · FY2020 · DE · contact PI
Natural Product-Inspired Approaches Toward the Development of Antivirulence and Species-Specific Inhibitors$380,777
R35 · FY2019 · GM · contact PI
Tool Compounds to Probe Multispecies Biofilms in the Human Oral Microbiome$363,477
R01 · FY2019 · DE · contact PI
Natural Product-Inspired Approaches Toward the Development of Antivirulence and Species-Specific Inhibitors$380,777
R35 · FY2018 · GM · contact PI
Tool Compounds to Probe Multispecies Biofilms in the Human Oral Microbiome$341,491
R01 · FY2018 · DE · contact PI
Natural Product-Inspired Approaches Toward the Development of Antivirulence and Species-Specific Inhibitors$380,777
R35 · FY2017 · GM · contact PI
Tool Compounds to Probe Multispecies Biofilms in the Human Oral Microbiome$370,106
R01 · FY2017 · DE · contact PI
Tool Compounds to Probe Multispecies Biofilms in the Human Oral Microbiome$400,683
R01 · FY2016 · DE · contact PI
Natural Product-Inspired Approaches Toward the Development of Antivirulence and Species-Specific Inhibitors$386,895
R35 · FY2016 · GM · contact PI
Formation, Tailoring and Incorporation of Piperazates in Kutzneride Biosynthesis$29,588
F32 · FY2011 · GM · contact PI
Formation, Tailoring and Incorporation of Piperazates in Kutzneride Biosynthesis$47,606
F32 · FY2010 · GM · contact PI